A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors
Clinical trial NCT07753590 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07753590
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2030-02-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.